BAM
TWST icon

Bosun Asset Management’s Twist Bioscience TWST Stock Holding History

Bosun Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,398
Closed -$487K – 227
2025
Q1 		$487K Buy
12,398
+4,307
+53% +$194K 0.21% 118
2024
Q4 		$376K Sell
8,091
-7,876
-49% -$356K 0.16% 142
2024
Q3 		$721K Buy
15,967
+324
+2% +$15.4K 0.34% 84
2024
Q2 		$771K Buy
+15,643
New +$638K 0.46% 57

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bosun Asset Management's TWST Position: Q2 2025 in Review

Bosun Asset Management sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 12,398 shares — an estimated $487K sold.

Bosun Asset Management first reported a position in TWST in Q2 2024 and held it in 4 quarters. The position peaked at $771K in Q2 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Bosun Asset Management reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Bosun Asset Management sold 12,398 Twist Bioscience shares in Q2 2025, an estimated $487K.
  • Bosun Asset Management first reported a position in Twist Bioscience in Q2 2024 and held it in 4 quarters.
  • Bosun Asset Management's Twist Bioscience position peaked at $771K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Bosun Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.